A detailed history of Genesee Capital Advisors, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Genesee Capital Advisors, LLC holds 13,364 shares of TEVA stock, worth $233,870. This represents 0.12% of its overall portfolio holdings.

Number of Shares
13,364
Previous 13,364 -0.0%
Holding current value
$233,870
Previous $217,000 10.6%
% of portfolio
0.12%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 25, 2022

BUY
$7.9 - $10.19 $15,602 - $20,125
1,975 Added 17.34%
13,364 $107,000
Q3 2021

Oct 14, 2021

BUY
$8.38 - $10.18 $95,439 - $115,940
11,389 New
11,389 $111,000
Q2 2021

Jul 20, 2021

SELL
$9.9 - $11.56 $112,751 - $131,656
-11,389 Closed
0 $0
Q1 2020

Apr 16, 2020

BUY
$6.69 - $13.45 $76,192 - $153,182
11,389 New
11,389 $102,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Genesee Capital Advisors, LLC Portfolio

Follow Genesee Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Genesee Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Genesee Capital Advisors, LLC with notifications on news.